The coronavirus pandemic has put a lot of our lab-based research on hold. But we don’t want to lose momentum or to let progress stall. We need your support, now more than ever, so that our researchers can make up for lost time.
‘We’re very proud that our researchers are doing everything they can to help overcome this crisis and to ensure that breast cancer research in the labs can continue as soon as possible.’ Dr Simon Vincent, Director of Research.
Read more about how Breast Cancer Now’s research has been affected by COVID-19.
Professor Lewis will investigate whether targeting two molecules, CXCR4 and VEGFA, can prevent relapse and the development of secondary tumours in triple negative breast cancer.
Dr Georgia Mavria is studying how a molecule called DOCK4 is involved in the spread of breast cancer to the brain. Her work could lead to new ways to prevent secondary tumours from growing in the brain and ultimately save lives.
Breast tumours can sometimes become resistant to treatment. Dr Yinyin Yuan will find out how the non-cancer cells that surround tumours help them develop resistance to avoid this.
Professor Robert Clarke is studying how a molecule called IL 1β helps breast cancer spread to the bones.
Professor Robert Clarke hopes to understand how ‘sleeping’ cancer stem cells awaken and find ways to stop this happening.
Professor Gartland is investigating whether certain molecules can be targeted with drugs to stop breast cancer spreading.